ADD5107: Week 10 Discussion 2: DSM-5 Criticism: A Follow-Up
Allen J Frances M.D.
DSM5 in Distress
PSYCHIATRY
DSM 5 Is Guide Not Bible —Ignore Its Ten Worst Changes APA approval of DSM-5 is a sad day for psychiatry.
Posted December 2, 2012
Reviewed by Ekua Hagan
Find a Therapist (City or Postcode)
This is the saddest moment in my 45-year career of studying,
practicing, and teaching psychiatry. The Board of Trustees of
the American Psychiatric Association has given its final ap‐
proval to a deeply flawed DSM 5 containing many changes
that seem clearly unsafe and scientifically unsound.
My best advice to clinicians, to the press, and to the general
public — be skeptical and don't follow DSM 5 blindly down a
road likely to lead to massive over-diagnosis and harmful
over-medication. Just ignore the 10 changes that make no
sense.
INTL
Brief background. DSM 5 got off to a bad start and was never
able to establish sure footing. Its leaders initially articulated a
premature and unrealizable goal: to produce a paradigm shift
in psychiatry. Excessive ambition combined with disorganized
execution led inevitably to many ill-conceived and risky
proposals.
These were vigorously opposed. More than fifty mental
health professional associations petitioned for an outside re‐
view of DSM 5 to provide an independent judgment of its
supporting evidence and to evaluate the balance between its
risks and benefits. Professional journals, the press, and the
public also weighed in, expressing widespread astonishment
about decisions that sometimes seemed not only to lack sci‐
entific support but also to defy common sense.
DSM 5 has neither been able to self correct nor willing to
heed the advice of outsiders. It has instead created a mostly
closed shop, circling the wagons and deaf to the repeated
and widespread warnings that it would lead to massive
misdiagnosis.
Fortunately, some of its most egregiously risky and unsup‐
portable proposals were eventually dropped under great ex‐
ternal pressure (most notably "psychosis risk," mixed
anxiety/depression, internet and sex addiction, rape as a
mental disorder, "hebephilia," cumbersome personality rat‐
ings, and sharply lowered thresholds for many existing disor‐
ders). But APA stubbornly refused to sponsor any indepen‐
dent review and has given final approval to the ten reckless
and untested ideas that are summarized below.
INTL
ARTICLE CONTINUES AFTER ADVERTISEMENT
For adults with tardive dyskinesia (TD)
Talk to your healthcare provider about simple dosing with INGREZZA
Get the TD Doctor Discussion Guide
Paid ad
Actor portrayalsActor portrayals
INGREZZA may cause serious side effects, including:
Sleepiness (somnolence). Do not drive, operate heavy machinery, or do other
See Important Safety Information/Prescribing Information
The history of psychiatry is littered with fad diagnoses that in
retrospect did far more harm than good. Yesterday's APA ap‐
proval makes it likely that DSM 5 will start a half or dozen or
more new fads which will be detrimental to the misdiagnosed
individuals and costly to our society.
The motives of the people working on DSM 5 have often
been questioned. They have been accused of having a finan‐
cial conflict of interest because some have (minimal) drug
company ties and also because so many of the DSM 5
changes will enhance Pharma profits by adding to our al‐
ready existing societal overdose of carelessly prescribed psy‐
chiatric medicine.
But I know the people working on DSM 5 and know this
charge to be both unfair and untrue. Indeed, they have made
some very bad decisions, but they did so with pure hearts
and not because they wanted to help the drug companies.
Their's is an intellectual, not financial, conflict of interest that
results from the natural tendency of highly specialized ex‐
perts to overvalue their pet ideas, to want to expand their
INTL
own areas of research interest, and to be oblivious to the dis‐
tortions that occur in translating DSM 5 to real-life clinical
practice (particularly in primary care where 80% of psychiatric
drugs are prescribed).
The APA's deep dependence on the publishing profits gener‐
ated by the DSM 5 business enterprise creates a far less pure
motivation. There is an inherent and influential conflict of in‐
terest between the DSM 5 public trust and DSM 5 as a best
seller. When its deadlines were consistently missed due to
poor planning and disorganized implementation, APA chose
quietly to cancel the DSM 5 field testing step that was meant
to provide it with a badly needed opportunity for quality con‐
trol. The current draft has been approved and is now being
rushed prematurely to press with incomplete field testing for
one reason only — so that DSM 5 publishing profits can fill
the big hole in APA's projected budget and return dividends
on the exorbitant cost of 25 million dollars that has been
charged to DSM 5 preparation.
This is no way to prepare or to approve a diagnostic system.
Psychiatric diagnosis has become too important in selecting
treatments, determining eligibility for benefits and services,
allocating resources, guiding legal judgments, creating
stigma, and influencing personal expectations to be left in the
hands of an APA that has proven itself incapable of producing
a safe, sound, and widely accepted manual.
New diagnoses in psychiatry are more dangerous than new
drugs because they influence whether or not millions of peo‐
ple are placed on drugs — often by primary care doctors after
brief visits. Before their introduction, new diagnoses deserve
INTL
PSYCHIATRY ESSENTIAL READS
Our High Lifetime Risk of Psychiatric Disorders
Getting a Mental Health Diagnosis
ARTICLE CONTINUES AFTER ADVERTISEMENT
Personalized treatment for adults
Premier Care for Trauma & PTSD
the same level of attention to safety that we devote to new
drugs. APA is not competent to do this.
So, here is my list of the DSM 5's 10 most potentially harmful
changes. I would suggest that clinicians not follow these at all
(or, at the very least, use them with extreme caution and at‐
tention to their risks); that potential patients be deeply skepti‐
cal, especially if the proposed diagnosis is being used as a
rationale for prescribing medication for you or for your child;
and that payers question whether some of these are suitable
for reimbursement. My goal is to minimize the harm that may
otherwise be done by unnecessary obedience to unwise and
arbitrary DSM 5 decisions.
INTL
DSM 5 will turn temper tantrums into a mental disorder — a
puzzling decision based on the work of only one research
group. We have no idea whatever how this untested new di‐
agnosis will play out in real-life practice settings, but my fear
is that it will exacerbate, not relieve, the already excessive
and inappropriate use of medication in young children.
During the past two decades, child psychiatry has already
provoked three fads- a tripling of Attention Deficit Disorder, a
more than 20-times increase in Autistic Disorder, and a 40-
times increase in childhood Bipolar Disorder. The field should
have felt chastened by this sorry track record and should en‐
gage itself now in the crucial task of educating practitioners
and the public about the difficulty of accurately diagnosing
children and the risks of over- medicating them. DSM 5
should not be adding a new disorder likely to result in a new
fad and even more inappropriate medication use in vulnera‐
ble children.
1. Normal grief will become Major Depressive Disorder, thus
medicalizing and trivializing our expectable and neces‐
sary emotional reactions to the loss of a loved one and
substituting pills and superficial medical rituals for the
deep consolations of family, friends, religion, and the re‐
siliency that comes with time and the acceptance of the
limitations of life.
2. The everyday forgetting characteristic of old age will now
be misdiagnosed as Minor Neurocognitive Disorder, cre‐
ating a huge false positive population of people who are
not at special risk for dementia. Since there is no effective
treatment for this 'condition' (or for dementia), the label
provides absolutely no benefit (while creating great anxi‐
ety) even for those at true risk for later developing de‐
INTL
mentia. It is a dead loss for the many who will be
mislabeled.
3. DSM 5 will likely trigger a fad of Adult Attention Deficit
Disorder leading to widespread misuse of stimulant drugs
for performance enhancement and recreation and con‐
tributing to the already large illegal secondary market in
diverted prescription drugs.
4. Excessive eating 12 times in 3 months is no longer just a
manifestation of gluttony and the easy availability of really
great tasting food. DSM 5 has instead turned it into a psy‐
chiatric illness called Binge Eating Disorder.
5. The changes in the DSM 5 definition of Autism will result
in lowered rates — 10 percent according to estimates by
the DSM 5 work group, perhaps 50 percent according to
outside research groups. This reduction can be seen as
beneficial in the sense that the diagnosis of Autism will be
more accurate and specific- but advocates understand‐
ably fear a disruption in needed school services. Here the
DSM 5 problem is not so much a bad decision, but the
misleading promises that it will have no impact on rates of
disorder or of service delivery. School services should be
tied more to educational need, less to a controversial
psychiatric diagnosis created for clinical (not educational)
purposes and whose rate is so sensitive to small changes
in definition and assessment.
6. First-time substance abusers will be lumped in definition‐
ally in with hardcore addicts despite their very different
treatment needs and prognosis and the stigma this will
cause.
7. DSM 5 has created a slippery slope by introducing the
concept of Behavioral Addictions that eventually can
spread to make a mental disorder of everything we like to
INTL
do a lot. Watch out for careless overdiagnosis of internet
and sex addiction and the development of lucrative treat‐
ment programs to exploit these new markets.
8. DSM 5 obscures the already fuzzy boundary been
Generalized Anxiety Disorder and the worries of every‐
day life. Small changes in definition can create millions of
anxious new "patients" and expand the already wide‐
spread practice of inappropriately prescribing addicting
anti-anxiety medications.
9. DSM 5 has opened the gate even further to the already
existing problem of misdiagnosis of PTSD in forensic
settings.
DSM 5 has dropped its pretension to being a paradigm shift
in psychiatric diagnosis and instead (in a dramatic 180-degree
turn) now makes the equally misleading claim that it is a con‐
servative document that will have minimal impact on the rates
of psychiatric diagnosis and in the consequent provision of
inappropriate treatment. This is an untenable claim that DSM
5 cannot possibly support because, for completely unfath‐
omable reasons, it never took the simple and inexpensive
step of actually studying the impact of DSM on rates in real-
world settings.
Except for autism, all the DSM 5 changes loosen diagnosis
and threaten to turn our current diagnostic inflation into diag‐
nostic hyperinflation. Painful experience with previous DSMs
teaches that if anything in the diagnostic system can be mis‐
used and turned into a fad, it will be. Many millions of people
with normal grief, gluttony, distractibility, worries, reactions to
stress, the temper tantrums of childhood, the forgetting of old
INTL
ARTICLE CONTINUES AFTER ADVERTISEMENT
Free Pdf
Download
Download
age, and "behavioral addictions" will soon be mislabeled as
psychiatrically sick and given inappropriate treatment.
People with real psychiatric problems that can be reliably di‐
agnosed and effectively treated are already badly short‐
changed. DSM 5 will make this worse by diverting attention
and scarce resources away from the truly ill and toward peo‐
ple with the everyday problems of life who will be harmed,
not helped, when they are mislabeled as mentally ill.
Our patients deserve better, society deserves better, and the
mental health professions deserve better. Caring for the men‐
tally ill is a noble and effective profession. But we have to
know our limits and stay within them.
DSM 5 violates the most sacred (and most frequently ig‐
nored) tenet in medicine: First Do No Harm! That's why this is
such a sad moment.
INTL
ADVERTISEMENT
About the Author
Allen Frances, M.D., was the chair of the
DSM-IV Task Force and is currently a
professor emeritus at Duke.
Online: Twitter, Twitter
More from Allen J Frances M.D.
CHRONIC PAIN 5 MIN READ
INTL
Pharma Corruption Started the Opioid Epidemic
GENETICS 5 MIN READ
Patient-centered vs. Lab-centered "Personalized Medicine" Treat the patient as a person, not as a bunch of lab test results.
More from Psychology Today
PSYCHIATRY 3 MIN READ
INTL
Heat Intolerance and Psychiatric Medications Though 1 in 6 Americans take psychiatric medications, many aren't
aware of the need to be mindful of the heat in summer months.
PSYCHIATRY 3 MIN READ
The Difference Between a Psychologist and a Psychiatrist A major difference between the two types of experts is that
psychiatrists can prescribe medication.
INTL
PSYCHIATRY 3 MIN READ
Mold Toxicity: A Common Cause of Psychiatric Symptoms Could your depression, anxiety, brain fog and insomnia be due to
mold toxicity?
PSYCHIATRY 5 MIN READ
The Five Most Influential Psychiatric Drugs of All Time
INTL
The drugs that forever changed the landscape of psychiatry.
PSYCHIATRY 4 MIN READ
20 Questions to Ask Your New Therapist Most therapists will offer a free initial consultation, so it can be
beneficial to prepare questions to find one who's a good fit.
PSYCHIATRY 6 MIN READ
INTL
NAC: The Amino Acid That Turns Psychiatry on Its Head
PSYCHIATRY 5 MIN READ
My Exploration of Low Dose Naltrexone's Benefits LDN's capacity to modulate the immune system has wide potential
applicability.
INTL
PSYCHIATRY 4 MIN READ
The Five Most Influential Psychiatric Thinkers of All Time The iconic figures behind psychiatry's most consequential ideas
Find a Therapist Get the help you need from a therapist near you–a FREE service
from Psychology Today.
Countries:
City or Postcode
INTL
Australia
Austria
Belgium
Canada
Denmark
Hong Kong
Ireland
New Zealand
Singapore
South Africa
Sweden
Switzerland
United Kingdom
United States
Are you a Therapist? Get Listed Today
INTL
Subscribe Today
About Editorial Process Privacy Terms Accessibility
International
Psychology Today © 2023 Sussex Publishers, LLC
INTL